Do not use if the solution appears cloudy, discolored, or contains particles
Conducted between June 2011 and March 2013 at 191 sites in 27 countries in Europe, North America, South America, Asia, and Australia this was a randomised, placebo-controlled trial designed to evaluate the efficacy and safety of 3mg liraglutide 'injected subcutaneously once daily, as an adjunct to a reduced-calorie diet and increased physical activity, for weight management in overweight or obese adults who did not have diabetes at baseline.' A total of 3,731 individuals participated in the trial, of whom 2,487 were assigned to lifestyle intervention plus liraglutide and 1,244 to lifestyle intervention with a placebo
At that scale, small differences can translate to large numbers of patients affected
By managing the dosage of GLP-1 medications and ensuring adequate protein consumption, patients can maintain or even increase their muscle mass while using these drugs
Before BMI became the standard, MetLife one of the biggest US life insurers used heightweight tables that flagged any deviation from your baseline
